Zhejiang Xianju Pharmaceutical Coltd
Zhejiang Xianju Pharmaceutical Co., Ltd., commonly referred to as Xianju Pharma, is a prominent player in the pharmaceutical industry, headquartered in Xianju, China. Established in 1995, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of traditional Chinese medicine and modern pharmaceuticals. With a strong focus on research and development, Xianju Pharma offers a diverse range of core products, including active pharmaceutical ingredients (APIs) and finished dosage forms. Their commitment to innovation and quality has positioned them as a trusted supplier in both domestic and international markets. Notable achievements include certifications from various regulatory bodies, underscoring their dedication to maintaining high industry standards.
DitchCarbon Score
How does Zhejiang Xianju Pharmaceutical Coltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zhejiang Xianju Pharmaceutical Coltd's score of 6 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zhejiang Xianju Pharmaceutical Coltd's reported carbon emissions
In 2022, Zhejiang Xianju Pharmaceutical Co., Ltd. reported total carbon emissions of approximately 39,044,710 kg CO2e. This figure includes 1,587,420 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 42,670,960 kg CO2e from Scope 2 emissions, primarily related to purchased electricity. Additionally, the company recorded Scope 3 emissions of about 85,290 kg CO2e, which encompass indirect emissions from the value chain. Comparatively, in 2021, the total emissions were approximately 35,344,690 kg CO2e, with Scope 1 emissions at 1,033,790 kg CO2e and Scope 2 emissions at 44,813,300 kg CO2e. The Scope 3 emissions for that year were about 44,940 kg CO2e. In 2020, the total emissions were around 36,699,350 kg CO2e, with Scope 1 emissions of 1,723,650 kg CO2e and Scope 2 emissions of 81,205,200 kg CO2e, while Scope 3 emissions were approximately 57,670 kg CO2e. Despite these figures, there are currently no publicly disclosed reduction targets or climate pledges from Zhejiang Xianju Pharmaceutical, indicating a potential area for improvement in their climate commitments. The company operates within an industry context that increasingly prioritises sustainability and carbon footprint reduction, making it essential for them to establish clear climate goals moving forward.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 1,723,650 | 0,000,000 | 0,000,000 |
| Scope 2 | 81,205,200 | 00,000,000 | 00,000,000 |
| Scope 3 | 57,670 | 00,000 | 00,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zhejiang Xianju Pharmaceutical Coltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
